10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q2 2024

Filing Information

Form Type	10-Q
Accession Number	`0001628280-24-022215`
Period End Date	20240331
Filing Date	20240509
Fiscal Year	2024
Fiscal Period	Q2
XBRL Instance	arwr-20240331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 144 Income Statement 178 Cash Flow Statement 126 Stockholders Equity 82

Balance Sheet 144 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$134.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$134.96M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	124.13M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	124.13M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.70M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	107.31M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	107.31M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	124.13M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	124.13M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.31M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.31M	shares	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$292.74M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$292.74M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$395.41M	USD	Point-in-time
Available-for-sale securities, at fair value	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$395.41M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$8.81M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$8.81M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$11.02M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$11.02M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.08M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.08M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.51M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.51M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$541.65M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$541.65M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$419.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$419.52M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$290.26M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$290.26M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$359.25M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$359.25M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$9.41M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$9.41M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$10.26M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$10.26M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$44.63M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$44.63M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$45.30M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$45.30M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$210.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$210.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$210.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$210.00K	USD	Point-in-time
Total Assets	`Assets`	$955.15M	USD	Point-in-time
Total Assets	`Assets`	$955.15M	USD	Point-in-time
Total Assets	`Assets`	$765.55M	USD	Point-in-time
Total Assets	`Assets`	$765.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$35.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$35.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.52M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.52M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$37.05M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$37.05M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$39.76M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$39.76M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$17.96M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$17.96M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$13.74M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$13.74M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$5.29M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$5.29M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$10.56M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$10.56M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$866.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$866.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$435.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$435.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$573.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$573.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$65.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$65.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$105.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$105.46M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$113.63M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$113.63M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$104.61M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$104.61M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$280.94M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$280.94M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$268.33M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$268.33M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$372.93M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$372.93M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$394.57M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$394.57M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 124,133 and 107,312 shares	`CommonStockValue`	$200.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 124,133 and 107,312 shares	`CommonStockValue`	$200.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 124,133 and 107,312 shares	`CommonStockValue`	$217.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 shares; issued and outstanding 124,133 and 107,312 shares	`CommonStockValue`	$217.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.30B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.30B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.77B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.77B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.22M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.22M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.09M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.28B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.28B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.03B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.03B	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$271.34M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$271.34M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$483.79M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$483.79M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$11.61M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$11.61M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.82M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.82M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$495.40M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$495.40M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$955.15M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$955.15M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$765.55M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$765.55M	USD	Point-in-time

Income Statement 178 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$146.27M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$146.27M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.55M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.55M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$208.81M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$208.81M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$158.58M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$158.58M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$217.61M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$217.61M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$101.12M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$101.12M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$74.88M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$74.88M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$48.67M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$48.67M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$23.22M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$23.22M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$44.21M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$44.21M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$25.07M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$25.07M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$126.19M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$126.19M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$98.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$98.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$202.78M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$202.78M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$266.29M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$266.29M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$48.16M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$48.16M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$6.03M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$6.03M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$-262.74M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$-262.74M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$-126.19M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$-126.19M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$9.05M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterestAndDividend`	$9.05M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterestAndDividend`	$4.56M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$4.56M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$6.25M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$6.25M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$7.24M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterestAndDividend`	$7.24M	USD	2 Qtrs
Interest expense	`InterestExpense`	$12.61M	USD	2 Qtrs
Interest expense	`InterestExpense`	$12.61M	USD	2 Qtrs
Interest expense	`InterestExpense`	$7.24M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.24M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.91M	USD	2 Qtrs
Interest expense	`InterestExpense`	$7.91M	USD	2 Qtrs
Interest expense	`InterestExpense`	$5.06M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.06M	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$515.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$515.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$610.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$610.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$189.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$189.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$8.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$8.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-805.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-805.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-149.00K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-149.00K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-2.95M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-2.95M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-489.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-489.00K	USD	1 Quarter
(Loss) income before income tax (benefit) expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.88M	USD	2 Qtrs
(Loss) income before income tax (benefit) expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.88M	USD	2 Qtrs
(Loss) income before income tax (benefit) expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$47.68M	USD	1 Quarter
(Loss) income before income tax (benefit) expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$47.68M	USD	1 Quarter
(Loss) income before income tax (benefit) expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-265.69M	USD	2 Qtrs
(Loss) income before income tax (benefit) expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-265.69M	USD	2 Qtrs
(Loss) income before income tax (benefit) expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-127.00M	USD	1 Quarter
(Loss) income before income tax (benefit) expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-127.00M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$17.00K	USD	2 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$17.00K	USD	2 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-3.31M	USD	2 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-3.31M	USD	2 Qtrs
Net (loss) income including noncontrolling interest	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net (loss) income including noncontrolling interest	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net (loss) income including noncontrolling interest	`ProfitLoss`	$-262.37M	USD	2 Qtrs
Net (loss) income including noncontrolling interest	`ProfitLoss`	$-262.37M	USD	2 Qtrs
Net (loss) income including noncontrolling interest	`ProfitLoss`	$-41.81M	USD	1 Quarter
Net (loss) income including noncontrolling interest	`ProfitLoss`	$-41.81M	USD	1 Quarter
Net (loss) income including noncontrolling interest	`ProfitLoss`	$5.87M	USD	2 Qtrs
Net (loss) income including noncontrolling interest	`ProfitLoss`	$5.87M	USD	2 Qtrs
Net (loss) income including noncontrolling interest	`ProfitLoss`	$47.68M	USD	1 Quarter
Net (loss) income including noncontrolling interest	`ProfitLoss`	$47.68M	USD	1 Quarter
Net (loss) income including noncontrolling interest	`ProfitLoss`	$-127.00M	USD	1 Quarter
Net (loss) income including noncontrolling interest	`ProfitLoss`	$-127.00M	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.21M	USD	2 Qtrs
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.21M	USD	2 Qtrs
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.49M	USD	2 Qtrs
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.49M	USD	2 Qtrs
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.70M	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.70M	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-999.00K	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-999.00K	USD	1 Quarter
Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$48.67M	USD	1 Quarter
Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$48.67M	USD	1 Quarter
Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-125.30M	USD	1 Quarter
Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-125.30M	USD	1 Quarter
Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-258.16M	USD	2 Qtrs
Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-258.16M	USD	2 Qtrs
Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$7.35M	USD	2 Qtrs
Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$7.35M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.07	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.07	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-2.24	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-2.24	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.46	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.46	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.24	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.24	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.45	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.45	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.39M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.39M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.76M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.76M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	123.28M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	123.28M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.31M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.31M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	123.28M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	123.28M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.31M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.31M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	107.89M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	107.89M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	108.14M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	108.14M	shares	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.91M	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.91M	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.12M	USD	2 Qtrs
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.12M	USD	2 Qtrs
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$216.00K	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$216.00K	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	2 Qtrs
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-196.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-196.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-74.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-74.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-56.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-56.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$58.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$58.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-126.84M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-126.84M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-260.25M	USD	2 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-260.25M	USD	2 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$47.60M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$47.60M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.67M	USD	2 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.67M	USD	2 Qtrs

Cash Flow Statement 126 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-262.37M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-262.37M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-41.81M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-41.81M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.87M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$5.87M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$47.68M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$47.68M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-127.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-127.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$40.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$40.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$37.44M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$37.44M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$8.79M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$8.79M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.36M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.36M	USD	2 Qtrs
Amortization (accretion) of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-896.00K	USD	2 Qtrs
Amortization (accretion) of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-896.00K	USD	2 Qtrs
Amortization (accretion) of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$82.00K	USD	2 Qtrs
Amortization (accretion) of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$82.00K	USD	2 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	-	USD	2 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	-	USD	2 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	$80.00K	USD	2 Qtrs
Realized gain on investments	`RealizedInvestmentGainsLosses`	$80.00K	USD	2 Qtrs
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$12.61M	USD	2 Qtrs
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$12.61M	USD	2 Qtrs
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$7.91M	USD	2 Qtrs
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$7.91M	USD	2 Qtrs
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$12.61M	USD	1 Quarter
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$12.61M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$68.02M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$68.02M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-20.31M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-20.31M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.64M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.64M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.69M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.69M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-8.40M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-8.40M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-27.28M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-27.28M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-11.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-11.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-99.14M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-99.14M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-866.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-866.00K	USD	2 Qtrs
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$1.21M	USD	2 Qtrs
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$1.21M	USD	2 Qtrs
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$4.42M	USD	2 Qtrs
Operating lease, net	`IncreaseDecreaseInOperatingLeaseLiability`	$4.42M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-107.19M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-107.19M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-210.22M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-210.22M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$66.22M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$66.22M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$102.73M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$102.73M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$192.53M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$192.53M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$309.98M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$309.98M	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$208.62M	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$208.62M	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$141.99M	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$141.99M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-116.76M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-116.76M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-204.10M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-204.10M	USD	2 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$1.10M	USD	2 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$1.10M	USD	2 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$1.78M	USD	2 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$1.78M	USD	2 Qtrs
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$429.26M	USD	2 Qtrs
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$429.26M	USD	2 Qtrs
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from the issuance of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	-	USD	2 Qtrs
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	-	USD	2 Qtrs
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	$250.00M	USD	2 Qtrs
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	$250.00M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$251.10M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$251.10M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$431.04M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$431.04M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$27.15M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$27.15M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$16.73M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$16.73M	USD	2 Qtrs
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.00K	USD	2 Qtrs
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.00K	USD	2 Qtrs
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-196.00K	USD	2 Qtrs
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-196.00K	USD	2 Qtrs
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$134.96M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$134.96M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.70M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.70M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$134.96M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$134.96M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.70M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.70M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.89M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$-3.01M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$-3.01M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$7.26M	USD	2 Qtrs
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$7.26M	USD	2 Qtrs
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$12.83M	USD	2 Qtrs
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$12.83M	USD	2 Qtrs

Stockholders Equity 82 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$495.40M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$495.40M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.75M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.75M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.61M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.61M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.69M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.69M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.39M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.39M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$520.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$520.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$267.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$267.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$576.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$576.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.51M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.51M	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	154,347.00	shares	2 Qtrs
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	154,347.00	shares	2 Qtrs
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Common stock issued, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$429.26M	USD	1 Quarter
Common stock issued, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$429.26M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-196.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-196.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-74.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-74.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-56.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-56.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$58.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$58.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.91M	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.91M	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.12M	USD	2 Qtrs
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.12M	USD	2 Qtrs
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$216.00K	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$216.00K	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	2 Qtrs
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-135.38M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-262.37M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-262.37M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-41.81M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-41.81M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.87M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$5.87M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$47.68M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$47.68M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-127.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-127.00M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$287.16M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$173.71M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$495.40M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$495.40M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.